Aroa Biosurgery Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Brian Ward
Chief executive officer
NZ$1.2m
Total compensation
| CEO salary percentage | 46.0% |
| CEO tenure | 16.7yrs |
| CEO ownership | 9.6% |
| Management average tenure | 3.1yrs |
| Board average tenure | 9.3yrs |
Recent management updates
Recent updates
Here's Why We're Not At All Concerned With Aroa Biosurgery's (ASX:ARX) Cash Burn Situation
Mar 25
Why Investors Shouldn't Be Surprised By Aroa Biosurgery Limited's (ASX:ARX) 25% Share Price Plunge
Jan 30Aroa Biosurgery Limited's (ASX:ARX) Revenues Are Not Doing Enough For Some Investors
Nov 14Industry Analysts Just Made A Captivating Upgrade To Their Aroa Biosurgery Limited (ASX:ARX) Revenue Forecasts
Nov 02Aroa Biosurgery Limited's (ASX:ARX) Intrinsic Value Is Potentially 50% Above Its Share Price
Oct 25We Think Aroa Biosurgery (ASX:ARX) Can Easily Afford To Drive Business Growth
May 13Here's What Analysts Are Forecasting For Aroa Biosurgery Limited (ASX:ARX) After Its Annual Results
May 26An Intrinsic Calculation For Aroa Biosurgery Limited (ASX:ARX) Suggests It's 27% Undervalued
Mar 22Do Institutions Own Aroa Biosurgery Limited (ASX:ARX) Shares?
Feb 24Don't Ignore The Fact That This Insider Just Sold Some Shares In Aroa Biosurgery Limited (ASX:ARX)
Feb 24Aroa Biosurgery Limited's (ASX:ARX) Intrinsic Value Is Potentially 44% Above Its Share Price
Dec 16
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -NZ$8m |
| Jun 30 2023 | n/a | n/a | -NZ$4m |
| Mar 31 2023 | NZ$1m | NZ$552k | -NZ$396k |
| Dec 31 2022 | n/a | n/a | -NZ$1m |
| Sep 30 2022 | n/a | n/a | -NZ$2m |
| Jun 30 2022 | n/a | n/a | -NZ$5m |
| Mar 31 2022 | NZ$1m | NZ$542k | -NZ$8m |
| Dec 31 2021 | n/a | n/a | -NZ$10m |
| Sep 30 2021 | n/a | n/a | -NZ$11m |
| Jun 30 2021 | n/a | n/a | -NZ$15m |
| Mar 31 2021 | NZ$2m | NZ$483k | -NZ$19m |
Compensation vs Market: Brian's total compensation ($USD721.37K) is above average for companies of similar size in the Australian market ($USD295.42K).
Compensation vs Earnings: Brian's compensation has increased whilst the company is unprofitable.
CEO
Brian Ward
16.7yrs
Tenure
NZ$1,202,083
Compensation
Dr. Brian Ward, B.V.Sc, MBA(dist) has been Executive Director at Aroa Biosurgery Limited since September 21, 2007 and serves as its Managing Director and Chief Executive Officer. Dr. Ward is founded Mesynt...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | no data | NZ$1.20m | 9.62% NZ$ 16.9m | |
| CFO & Joint Company Secretary | 4.3yrs | NZ$627.01k | no data | |
| Chief Operating Officer | 1.3yrs | no data | no data | |
| Chief Scientific Officer | 2.4yrs | no data | 0.71% NZ$ 1.2m | |
| General Counsel | no data | no data | no data | |
| Director of Global Marketing & Strategy | no data | no data | no data | |
| Vice President of Quality | no data | no data | no data | |
| Joint Company Secretary | 3.8yrs | no data | no data |
3.1yrs
Average Tenure
Experienced Management: ARX's management team is considered experienced (3.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 16.7yrs | NZ$1.20m | 9.62% NZ$ 16.9m | |
| Independent Non-Executive Chairperson | 12.8yrs | NZ$168.56k | 0.82% NZ$ 1.4m | |
| Independent Non-Executive Director | 4.5yrs | NZ$128.39k | 0.35% NZ$ 608.2k | |
| Independent Non-Executive Director | 9.3yrs | NZ$147.37k | 0.14% NZ$ 241.0k | |
| Non-Executive Director | 16.2yrs | NZ$120.53k | 5.83% NZ$ 10.2m | |
| Independent Non-Executive Director | 1.5yrs | NZ$41.98k | no data | |
| Independent Non-Executive Director | less than a year | no data | no data |
9.3yrs
Average Tenure
57yo
Average Age
Experienced Board: ARX's board of directors are considered experienced (9.3 years average tenure).